Health Canada open data (page 13)
Health Canada publishes 2,987 open datasets on CanQuery: 58 with live tables. Preview tables, export CSV and follow original downloads.
- Datasets
- 2987
- Queryable datasets
- 58
- Mappable datasets
- 0
Datasets
- Guidance Document - Biomarkers Related to Drug or Biotechnology Product Development: Context, Structure and Format of Qualification Submissions ICH Topic E16
- Notice: Health Canada’s Approach to Digital Health Technologies
- Notice: ICH Guidance on Reporting Adverse Reactions to Marketed Health Products
- Notice: Improving access to medical devices information
- Guidance Document - Certificates of Supplementary Protection
- Guidance Document - E10: Choice of Control Group and Related Issues in Clinical Trials
- Guidance Document - Ethnic Factors in the Acceptability of Foreign Clinical Data ICH Topic E5(R1)
- Guidance Document - Guidance for Manufacturers of Human Immunodeficiency Virus (HIV) Rapid Diagnostic Tests (RDTs) for use at the Point of Care or for Self-Testing
- Guidance Document - International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Impurities in New Drug Substances - ICH Topic Q3A(R2)
- Guidance Document - Pharmaceutical Development ICH Topic Q8(R2)
- Guidance Document: Data Requirements for Safety and Effectiveness of Subsequent Entry Inhaled Corticosteroid Products Used for the Treatment of Asthma
- Health Canada's Clinical Trials Database
- Health Canada's special access programs: Overview
- Health Canada's special access programs: Request a drug
- Guidance Document: Tamper-resistance Formulations of Opioid Drug Products
- Notice: Health Canada’s Action Plan on Medical Devices: Continuously Improving Safety, Effectiveness and Quality - Informing Canadians about medical device treatment options
- Health Canada's special access programs: Request access to a medical device
- Hyperbaric Oxygen Therapy
- ICH E8(R1): General Considerations for Clinical Studies
- Insulin Products
- Insulin Pumps
- Labelling standard: Ethylene oxide gaseous products used in sterilization processes
- Licensing a Medical Device in Canada
- List of Drugs for an Urgent Public Health Need
- List of Recognized Standards for Medical Devices
- Listing of Drugs Currently Regulated as New Drugs (The New Drugs List)
- Listing of therapeutic products with paediatric information available in their labelling
- M3(R2): Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals
- Making urgently needed drugs available
- Medical batteries
- Medical Device reports and publications
- Medical Device Single Audit Program (MDSAP)
- Medical Test Kits for Home Use
- Notice: Guidance Document – Requirements in the Recognition Process for Medical Device Single Audit Program (MDSAP) Auditing Organizations
- Notice: Guidance Document: Post-Drug Identification Number (DIN) Changes
- Health Canada Fees Report Fiscal Year 2022-23
- Ministerial briefing material - November 2023
- Qualifying Notice - Lumakras
- Adoption of International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance: Q10: Pharmaceutical Quality System
- Arthritis
- Liver disease
- Blood health (non-cancer)
- Cancer therapies
- Diabetic health
- Digestive and bladder health
- Eye health
- Genetic disorders
- Heart health
- Immune system health
- Kidney disease